ZOGENIX INC
ZOGENIX INC
Share · US98978L2043 · ZGNX · A14V7E (XNMS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % -6,71 %

Company Profile for ZOGENIX INC Share

Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.

Invested Funds

The following funds have invested in: ZOGENIX INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
29,36
Percentage (%)
0,07 %

Company Data

Name ZOGENIX INC
Company Zogenix, Inc.
Symbol ZGNX
Website https://www.zogenix.com
Primary Exchange XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A14V7E
ISIN US98978L2043
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Stephen Farr
Country United States of America
Currency USD
Employees 0,3 T
Address 5959 Horton St Ste 500, 94608 Emeryville
IPO Date 2010-11-23

Stock Splits

Date Split
01.07.2015 1:8

Ticker Symbols

Name Symbol
NASDAQ ZGNX

More Shares

Investors who ZOGENIX INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BEFIMMO 18/26
BEFIMMO 18/26 Bond
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DIAGEO CAPITAL PLC 3.875% NTS 29/04/43
DIAGEO CAPITAL PLC 3.875% NTS 29/04/43 Bond
ELECTRONIC ARTS INC
ELECTRONIC ARTS INC Share
FIDELITY NATIONAL INFORMATION SERVICES INC
FIDELITY NATIONAL INFORMATION SERVICES INC Share
HSBC-ECON.SCA.US EQ. AC
HSBC-ECON.SCA.US EQ. AC Fund
INTEL CORP
INTEL CORP Share
JPMORGAN CHASE & CO
JPMORGAN CHASE & CO Share
MICROSOFT CORP
MICROSOFT CORP Share
NXP SEMICONDUCTORS NV
NXP SEMICONDUCTORS NV Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025